Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brent Ferrell

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Leukemia|December 3, 2021
Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemiaKathryn I Sunthankar, Matthew T Jenkins, Candace H Cote, et al.
Nature Communications|January 4, 2018
Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomicsDavid C Earl, P Brent Ferrell, Nalin Leelatian, et al.
Iscience|December 25, 2025
IFNγ signaling drives resistance to FLT3 inhibition in acute myeloid leukemiaAbraheem Khouqeer, Justin Cartailler, Christina Kim, et al.
Cancer Immunology Research|March 12, 2016
Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 TherapyAllison R Greenplate, Douglas B Johnson, Mikael Roussel, et al.
Journal of Leukocyte Biology|April 13, 2017
Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrowMikael Roussel, P Brent Ferrell, Allison R Greenplate, et al.
Experimental Hematology|February 19, 2026
TET2 loss enhances early response to inflammation in primitive and committed myeloid cellsMatthew T Jenkins, Rebecca Dubin, Kirsten M Dickerson, et al.
Circulation Research|January 30, 2025
Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic PotentialZachary A Kohutek, Heather L Caslin, Daniel J Fehrenbach, et al.
The Oncologist|March 2, 2019
Hematologic Complications of Immune Checkpoint InhibitorsElizabeth J Davis, Joe-Elie Salem, Arissa Young, et al.
Experimental Hematology|January 24, 2025
TET2-loss enhances immediate and time-resolved interferon-γ signaling responses across myeloid differentiationMatthew T Jenkins, Yunli E Chu, Alana M Franceski, et al.
Blood Cancer Discovery|May 6, 2022
Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid LeukemiaTiffany Guess, Chad R Potts, Pawan Bhat, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Leukemia|December 3, 2021
Isocitrate dehydrogenase mutations are associated with altered IL-1β responses in acute myeloid leukemiaKathryn I Sunthankar, Matthew T Jenkins, Candace H Cote, et al.
Nature Communications|January 4, 2018
Discovery of human cell selective effector molecules using single cell multiplexed activity metabolomicsDavid C Earl, P Brent Ferrell, Nalin Leelatian, et al.
Iscience|December 25, 2025
IFNγ signaling drives resistance to FLT3 inhibition in acute myeloid leukemiaAbraheem Khouqeer, Justin Cartailler, Christina Kim, et al.
Cancer Immunology Research|March 12, 2016
Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 TherapyAllison R Greenplate, Douglas B Johnson, Mikael Roussel, et al.
Journal of Leukocyte Biology|April 13, 2017
Mass cytometry deep phenotyping of human mononuclear phagocytes and myeloid-derived suppressor cells from human blood and bone marrowMikael Roussel, P Brent Ferrell, Allison R Greenplate, et al.
Experimental Hematology|February 19, 2026
TET2 loss enhances early response to inflammation in primitive and committed myeloid cellsMatthew T Jenkins, Rebecca Dubin, Kirsten M Dickerson, et al.
Circulation Research|January 30, 2025
Bone Marrow Niche in Cardiometabolic Disease: Mechanisms and Therapeutic PotentialZachary A Kohutek, Heather L Caslin, Daniel J Fehrenbach, et al.
The Oncologist|March 2, 2019
Hematologic Complications of Immune Checkpoint InhibitorsElizabeth J Davis, Joe-Elie Salem, Arissa Young, et al.
Experimental Hematology|January 24, 2025
TET2-loss enhances immediate and time-resolved interferon-γ signaling responses across myeloid differentiationMatthew T Jenkins, Yunli E Chu, Alana M Franceski, et al.
Blood Cancer Discovery|May 6, 2022
Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid LeukemiaTiffany Guess, Chad R Potts, Pawan Bhat, et al.
Pageof 5